Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System

Bivalent proximity-inducing compounds represent a novel class of small molecule therapeutics with exciting potential and new challenges. The most prominent examples of such compounds are utilized in targeted protein degradation where E3 ligases are hijacked to recruit a substrate protein to the prot...

Full description

Bibliographic Details
Main Authors: Sridhar Radhakrishnan, Oskar Hoff, Markus K. Muellner
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/23/8119
_version_ 1797462754897952768
author Sridhar Radhakrishnan
Oskar Hoff
Markus K. Muellner
author_facet Sridhar Radhakrishnan
Oskar Hoff
Markus K. Muellner
author_sort Sridhar Radhakrishnan
collection DOAJ
description Bivalent proximity-inducing compounds represent a novel class of small molecule therapeutics with exciting potential and new challenges. The most prominent examples of such compounds are utilized in targeted protein degradation where E3 ligases are hijacked to recruit a substrate protein to the proteasome via ubiquitination. In this review we provide an overview of the current state of E3 ligases used in targeted protein degradation, their respective ligands as well as challenges and opportunities that present themselves with these compounds.
first_indexed 2024-03-09T17:41:09Z
format Article
id doaj.art-f16c15a3f3504d74a93293d930042935
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T17:41:09Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-f16c15a3f3504d74a93293d9300429352023-11-24T11:36:55ZengMDPI AGMolecules1420-30492022-11-012723811910.3390/molecules27238119Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal SystemSridhar Radhakrishnan0Oskar Hoff1Markus K. Muellner2Celeris Therapeutics, Inc., Menlo Park, CA 94025, USACeleris Therapeutics, Inc., Menlo Park, CA 94025, USACeleris Therapeutics, Inc., Menlo Park, CA 94025, USABivalent proximity-inducing compounds represent a novel class of small molecule therapeutics with exciting potential and new challenges. The most prominent examples of such compounds are utilized in targeted protein degradation where E3 ligases are hijacked to recruit a substrate protein to the proteasome via ubiquitination. In this review we provide an overview of the current state of E3 ligases used in targeted protein degradation, their respective ligands as well as challenges and opportunities that present themselves with these compounds.https://www.mdpi.com/1420-3049/27/23/8119PROTACPICtargeted protein degradationproximity-inducing compoundE3 recruiterubiquitination
spellingShingle Sridhar Radhakrishnan
Oskar Hoff
Markus K. Muellner
Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
Molecules
PROTAC
PIC
targeted protein degradation
proximity-inducing compound
E3 recruiter
ubiquitination
title Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
title_full Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
title_fullStr Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
title_full_unstemmed Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
title_short Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
title_sort current challenges in small molecule proximity inducing compound development for targeted protein degradation using the ubiquitin proteasomal system
topic PROTAC
PIC
targeted protein degradation
proximity-inducing compound
E3 recruiter
ubiquitination
url https://www.mdpi.com/1420-3049/27/23/8119
work_keys_str_mv AT sridharradhakrishnan currentchallengesinsmallmoleculeproximityinducingcompounddevelopmentfortargetedproteindegradationusingtheubiquitinproteasomalsystem
AT oskarhoff currentchallengesinsmallmoleculeproximityinducingcompounddevelopmentfortargetedproteindegradationusingtheubiquitinproteasomalsystem
AT markuskmuellner currentchallengesinsmallmoleculeproximityinducingcompounddevelopmentfortargetedproteindegradationusingtheubiquitinproteasomalsystem